Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

LB-102

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 27, 2026 · PHASE 2 TRIAL

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

ClinicalTrials.gov

Phase 2 trial registry record for LB-102 in bipolar I disorder major depressive episode; no results yet reported.

PreliminaryLB Pharmaceuticals Bipolar I Disorder NCT07494305

Reported

Enrollment320 participants (ESTIMATED)

Study phasePHASE2

Primary outcome measureChange From Baseline in Montgomery Åsberg D…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support